Development and validation of a confirmatory method for the determination of tranquilisers and a β-blocker in porcine and bovine kidney by LC-MS/MS

References

• Batjoens P, Tsilikas K, Govaert Y, Degroodt JM, Srebnik S. 2000. Quantitative analysis of tranquillizers and the β-blocker carazolol by LC-MS-MS. In: Ginkel LA and Ruiter A, editors. Proceedings of the EuroResidue IV Conference on Residues of Veterinary Drugs in Food, Veldhoven, The Netherlands; p. 208–213. Berlin: Springer.
   Google Scholar
• Bock C, Gowik P, Stachel C. 2007. Matrix-comprehensive in-house validation and robustness check of a confirmatory method for the determination of four nitrofuran metabolites in poultry muscle and shrimp by LC–MS/MS. J Chromatogr B. 856:178–189.
   PubMed Web of Science ®Google Scholar
• Bock C, Stachel C, Gowik P. 2007. Validation of a confirmatory method for the determination of residues of four nitrofurans in egg by liquid chromatography-tandem mass spectrometry with the software InterVal. Anal Chim Acta. 586:348–358.
   PubMed Web of Science ®Google Scholar
• CRL. 2007. CRL Guidance Paper, CRLs’ view on state-of-the-art analytical methods for national residue control plans. Community Reference Laboratories (CRLs) for residues according to Council Directive 96/23/EC, December 2007. Available from: http://crl.fougeres.anses.fr/publicdoc/2013/EURL_Guidance_Concentrations_Minimales_Recommend%C3%A9es_Methodes_Analytiques.pdf
   Google Scholar
• Delahaut P, Brasseur PY, Dubois M. 2004. Multiresidue method for the detection of tranquillisers, xylazine, and a β-blocker in animal production by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 1054:373–378.
   PubMed Web of Science ®Google Scholar
• Delahaut P, Levaux C, Eloy P, Dubois M. 2003. Validation of a method for detecting and quantifying tranquillisers and a β-blocker in pig tissues by liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 483:335–340.
   Web of Science ®Google Scholar
• EMEA. 1997. Committee for veterinary medicinal products. Azaperone Summary report (2). EMEA/MRL/300/97-Final.London: The European Agency for the Evaluation of Medicinal Products. Available from: http://www.emea.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500010786.pdf
   Google Scholar
• EMEA. 1998a. Committee for veterinary medicinal products. Azaperone. Summary report (1). London: The European Agency for the Evaluation of Medicinal Products. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500010781.pdf
   Google Scholar
• EMEA. 1998b. Committee for veterinary medicinal products. Carazolol (extension to cattle). Summary report (3). EMEA/MRL/442/98-Final. London: The European Agency for the Evaluation of Medicinal Products. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500011319.pdf
   Google Scholar
• EMEA. 1999a. Committee for veterinary medicinal products. Carazolol (extension to cattle). Summary report (4). EMEA/MRL/592/99-Final. London: The European Agency for the Evaluation of Medicinal Products. Available from: http://www.emea.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500011359.pdf
   Google Scholar
• EMEA. 1999b. Committee for Veterinary Medicinal Products. Xylazine hydrochloride. Summary Report (1). EMEA//MRL/611/99-FINAL-corrigendum. London: The European Agency for the Evaluation of Medicinal Products. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015345.pdf
   Google Scholar
• EMEA. 2002. Committee for Veterinary Medicinal Products. Xylazine hydrochloride (Extension to dairy cows). Summary Report (2). EMEA//MRL/836/02-FINAL-corrigendum. London: The European Agency for the Evaluation of Medicinal Products. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015367.pdf
   Google Scholar
• European Commission. 2002. Commission Decision EC 2002/657/EC. Off J Eur Commun. L221:8–36.
   Google Scholar
• European Union. 2009. Commission Regulation EU No 37/2010. Off J Eur Commun. L15:1–72.
   Google Scholar
• He L, Wang J, Zhang G, Liu R, Fang B. 2012. Simultaneous determination of tranquilizers and carazolol residues in swine tissues by liquid chromatography-tandem mass spectrometry. Anal Lett. 45:1377–1389.
   Web of Science ®Google Scholar
• Innis R, Corrēa F, Synder S. 1979. Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes. Life Sci. 24:2255–2264.
   PubMed Web of Science ®Google Scholar
• Jülicher B, Gowik P, Uhlig S. 1999. A top-down in-house validation-based approach for the investigation of the measurement uncertainty using fractional factorial experiments. Analyst. 124:537–545.
   Web of Science ®Google Scholar
• Kaufmann A, Ryser B. 2001. Multiresidue analysis of tranquilizers and the beta-blocker Carazolol in meat by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 15:1747–1751.
   PubMed Web of Science ®Google Scholar
• Mitrowska K, Posyniak A, Zmudzki J. 2009. Rapid method for the determination of tranquilizers and a beta-blocker in porcine and bovine kidney by liquid chromatography with tandem mass spectrometry. Anal Chim Acta. 637:185–192.
   PubMed Web of Science ®Google Scholar
• Uhlig S, Gowik P, Radeck W. 2003. Performance of a matrix-comprehensive in-house validation study by means of an especially designed software. Anal Chim Acta. 483: 351–362.
   Web of Science ®Google Scholar
• Zhang J, Shao B, Yin J, Wu Y, Duan H. 2009. Simultaneous detection of residues of β-adrenergic receptor blockers and sedatives in animal tissues by high-performance liquid chromatography/tandem mass spectrometry. J Chromatogr B. 877:1915–1922.
   PubMed Web of Science ®Google Scholar